JENA

Jena Acquisition Corp II - 10-Q Summary (Q2 2025)

Business Context and Reporting Period

Jena Acquisition Corporation II (JENA) is a Cayman Islands exempted company incorporated on February 24, 2025, operating as a blank check company (SPAC). The reporting period covers the three months ended June 30, 2025, and the period from inception through June 30, 2025. The Company consummated its Initial Public Offering (IPO) on May 30, 2025, and has not yet selected a target for a Business Combination. It is classified as a shell company, an emerging growth company, and a smaller reporting company.

Key Financial Metrics

Material Changes and Operational Highlights

• IPO Completion: On May 30, 2025, the Company completed an IPO of 23,000,000 Units (including full over-allotment) at $10.00 per unit, generating gross proceeds of $230,000,000. Simultaneously, 225,000 Private Placement Units were sold to the Sponsor for $2,250,000.
• Trust Account: $230,000,000 was deposited into the Trust Account. As of June 30, 2025, the balance grew to $230,761,540 due to $761,540 in dividend and interest income.
• Expense Recognition: The Company recorded a significant non-cash advisory fee expense of $6,900,000, which is payable upon the completion of a Business Combination. This fee, along with formation and administrative costs, drove the net loss for the period.
• Share Structure: There are 23,225,000 Class A ordinary shares and 5,750,000 Class B ordinary shares outstanding as of August 13, 2025. The Class A shares subject to redemption are valued at approximately $10.03 per share.

Outlook, Risks, and Contingencies

• Business Combination Deadline: The Company has 24 months from the IPO closing (May 30, 2025) to complete an initial Business Combination. If unsuccessful, the Company will liquidate and redeem public shares.
• Liquidity: Management believes current working capital ($1.2 million) is sufficient for operations for at least one year. However, additional financing may be required if due diligence costs exceed estimates or if significant share redemptions occur.
• Deferred Fees: A deferred underwriting fee of $6,900,000 and an advisory fee of $6,900,000 are contingent upon the successful completion of a Business Combination.
• Risk Factors: Risks include the inability to find a suitable target, changes in international trade policies/tariffs affecting potential targets, and the possibility that the post-combination share price may fall below the redemption price.

Investor Verification Checklist

• Trust Account Balance: Verify the current balance of the Trust Account ($230.76M) and the per-share redemption value (~$10.03) to assess liquidation value.
• Contingent Liabilities: Confirm the status of the $6.9M deferred underwriting fee and $6.9M advisory fee, which are only payable upon a successful merger.
• Working Capital Runway: Assess the $1.18M cash on hand against the $2,500/month administrative fee and potential due diligence costs to ensure the 24-month timeline is feasible.
• Sponsor Commitments: Review the Sponsor's indemnity obligations regarding third-party claims that could reduce Trust Account funds below $10.00 per share.
• Share Dilution: Monitor the conversion ratio of Class B founder shares (5.75M shares) to Class A shares, which is adjusted to maintain a 20% ownership stake post-combination.